References
- PONIKOWSKI, P., VOORS, A.A., ANKER, S.D., BUENO, H., CLELAND, J.G.F.F., COATS, A.J.S.S., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2016;37(27).
- REINA-COUTO, M., PEREIRA-TERRA, P., QUELHAS-SANTOS, J., SILVA-PEREIRA, C., ALBINO-TEIXEIRA, A., SOUSA, T. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets. Front. Physiol. 2021;12(October).
- MURPHY, S.P., KAKKAR, R., MCCARTHY, C.P., JANUZZI, J.L. Inflammation in Heart Failure: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020;75(11):1324–1340.
- DELCEA, C., BUZEA, C.A., DAN, G.A. The Neutrophil to Lymphocyte Ratio in Heart Failure: A Comprehensive Review. Rom. J. Intern. Med. 2019;57(4):296–314.
- CHUNG, I., LIP, G.Y.H. Platelets and heart failure. Eur. Heart J. 2006;27(22):2623–2631.
- AUKRUST, P., UELAND, T., MÜLLER, F., ANDREASSEN, A.K., NORDØY, I., AAS, H., et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998;97(12):1136–1143.
- RONDINA, M.T., WEYRICH, A.S., ZIMMERMAN, G.A. Platelets as cellular effectors of inflammation in vascular diseases. Circ. Res. 2013;112(11):1506–19.
- DETOPOULOU, P., NOMIKOS, T., FRAGOPOULOU, E., CHRYSOHOOU, C., ANTONOPOULOU, S. Platelet activating factor in heart failure: Potential role in disease progression and novel target for therapy. Curr. Heart Fail. Rep. 2013;10(2):122–129.
- SEREBRUANYA, V.L., MCKENZIE, M.E., MEISTERA, A.F., FUZAYLOV, S.Y., GURBEL, P.A., ATAR, D., et al. Whole blood impedance aggregometry for the assessment of platelet function in patients with congestive heart failure (EPCOT trial). Eur. J. Heart Fail. 2002;4(4):461–467.
- SEREBRUANY, V.L., MURUGESAN, S.R., POTHULA, A., ATAR, D., LOWRY, D.R., O’CONNOR, C.M., et al. Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy. Eur. J. Heart Fail. 1999;1(3):243–249.
- ERNE, P., WARDLE, J., SANDERS, J., LEWIS, S.M., MASERI, A. Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thromb. Haemost. 1988;59(2):259–263.
- GURBEL, P.A., GATTIS, W.A., FUZAYLOV, S.F., GAULDEN, L., HASSELBLAD, V., SEREBRUANY, V.L., et al. Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes?. Am. Heart J. 2002;143(6):1068–1075.
- O’CONNOR, C.M., GURBEL, P.A., SEREBRUANY, V.L. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am. J. Cardiol. 1999;83(9):1345–1349.
- JAFRI, S.M., OZAWA, T., MAMMEN, E., LEVINE, T.B., JOHNSON, C., GOLDSTEIN, S. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur. Heart J. 1993;14(2):205–12.
- TOUYZ, R.M., SCHIFFRIN, E.L. Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension. Hypertension 1993;22(6):853–62.
- VADUGANATHAN, M., GREENE, S.J., BUTLER, J., SABBAH, H.N., SHANTSILA, E., LIP, G.Y.H., et al. The immunological axis in heart failure: Importance of the leukocyte differential. Heart Fail. Rev. 2013;18(6):835–845.
- A, C., V, B., A, N., A, C., P, T.-B. Administration to Mouse of Endotoxin From Gram-Negative Bacteria Leads to Activation and Apoptosis of T Lymphocytes. Eur. J. Immunol. 1998;28(2).
- HUEHNERGARTH, K. V, MOZAFFARIAN, D., SULLIVAN, M.D., CRANE, B.A., WILKINSON, C.W., LAWLER, R.L., et al. Usefulness of Relative Lymphocyte Count as an Independent Predictor of Death / Urgent Transplant in Heart Failure 2005;95:10–13.
- MAISEL, A.S., KNOWLTON, K.U., FOWLER, P., REARDEN, A., ZIEGLER, M.G., MOTULSKY, H.J., et al. Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J. Clin. Invest. 1990;85(2):462–7.
- THOMSON, S.P., MCMAHON, L.J., NUGENT, C.A. Endogenous cortisol: A regulator of the number of lymphocytes in peripheral blood. Clin. Immunol. Immunopathol. 1980;17(4):506–514.
- HURDLE, A.D., GYDE, O.H., WILLOUGHBY, J.M. Occurrence of lymphopenia in heart failure. J. Clin. Pathol. 1966;19(1):60–64.
- BALTA, S., OZTURK, C. The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets 2015;26(7):680–681.
- DURMUS, E., KIVRAK, T., GERIN, F., SUNBUL, M., SARI, I., ERDOGAN, O. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure. Arq. Bras. Cardiol. 2015;(June 2012):606–613.
- YE, G., CHEN, Q., CHEN, X., LIU, Y., YIN, T., MENG, Q., et al. The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: A cohort study. Sci. Rep. 2019;9(1):1–8.
- DELCEA, C., BUZEA, C.A., VIJAN, A., DRAGHICI, A., STOICHITOIU, L.E., DAN, G.A., et al. Comparative role of hematological indices for the assessment of in-hospital outcome of heart failure patients. Scand. Cardiovasc. J. 2021;55(4).
- ARFSTEN, H., CHO, A., PRAUSMÜLLER, S., SPINKA, G., NOVAK, J., GOLIASCH, G., et al. Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer. Front. Cardiovasc. Med. 2021;8(October):1–10.
- DAHLEN, B., SCHULZ, A., GÖBEL, S., TRÖBS, S.O., SCHWUCHOW-THONKE, S., SPRONK, H.M., et al. The impact of platelet indices on clinical outcome in heart failure: results from the MyoVasc study. ESC Hear. Fail. 2021;8(4):2991–3001.
- TAMAKI, S., NAGAI, Y., SHUTTA, R., MASUDA, D. Combination of Neutrophil-to-Lymphocyte and Platelet-to- Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study. J. Am. Heart Assoc. 2023;12(1):e026326.
- UÇAR, F.M., AÇAR, B., GUL, M., ÖZEKE, Ö., AYDOGDU, S. The association between platelet/lymphocyte ratio and coronary artery disease severity in asymptomatic low ejection fraction patients. Korean Circ. J. 2016;46(6):821–826.
- SUN, X.P., LI, J., ZHU, W.W., LI, D.B., CHEN, H., LI, H.W., et al. Impact of Platelet-to-Lymphocyte Ratio on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction. Angiology 2016;68(4):346–353.
- INTAN, R.E., ALKAFF, F.F., OKTAVIONO, Y.H., NUGRAHA, R.A., OCTORA, T.N., JONATAN, M., et al. Retrospective Study of the Association Between Platelet-to-Lymphocyte Ratio in Patients with Acute Coronary Syndrome on Admission to a Rural Referral Center in East Java, Indonesia, and the Incidence of New Symptomatic Heart Failure at 6 Months. Med. Sci. Monit. 2022;28:1–9.
- POURAFKARI, L., WANG, C.K., TAJLIL, A., AFSHAR, A.H., SCHWARTZ, M., NADER, N.D. Platelet-lymphocyte ratio in prediction of outcome of acute heart failure. Biomark. Med. 2018;12(1):63–70.
- TURCATO, G., SANCHIS-GOMAR, F., CERVELLIN, G., ZORZI, E., SIVERO, V., SALVAGNO, G.L., et al. Evaluation of neutrophil-lymphocyte and platelet-lymphocyte ratios as predictors of 30-day mortality in patients hospitalized for an episode of acute decompensated heart failure. J. Med. Biochem. 2019;38(4):452–460.
- TABAN SADEGHI, M., ESGANDARIAN, I., NOURI-VASKEH, M., GOLMOHAMMADI, A., RAHVAR, N., TEIMOURIZAD, A. Role of circulatory leukocyte based indices in short-term mortality of patients with heart failure with reduced ejection fraction. Med. Pharm. Reports 2020;93(4):351–356.
- YAO, C., WANG, L., SHI, F., CHEN, R., LI, B., LIU, W., et al. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with heart failure. Int. J. Med. Sci. 2021;18(7):1592–1599.
- HEIDARPOUR, M., BASHIRI, S., VAKHSHOORI, M., HESHMAT-GHAHDARIJANI, K., KHANIZADEH, F., FERDOWSIAN, S., et al. The association between platelet-to-lymphocyte ratio with mortality among patients suffering from acute decompensated heart failure. BMC Cardiovasc. Disord. 2021;21(1):454.
- HUANG, W.M., CHENG, H.M., HUANG, C.J., GUO, C.Y., LU, D.Y., LEE, C.W., et al. Hemographic indices are associated with mortality in acute heart failure /692/4019/592/75/74 /692/4019/592/75/230 article. Sci. Rep. 2017;7(1):1–9.
- DEMIR, M., DUYULER, P.T., GURAY, U., CELIK, M.C. Platelet to Lymphocyte Ratio on Admission and Prognosis in Patients with Acute Cardiogenic Pulmonary Edema. J. Emerg. Med. 2018;55(4):465–471.
- SIEDLECKI, Ł., SZYGUŁA-JURKIEWICZ, B., SZCZUREK, W., PYKA, Ł., NIEDZIELA, J., GĄSIOR, M. Mortality risk factors in patients with advanced heart failure and diabetes mellitus. Kardiol. Pol. 2019;77(6):604–609.
- BALCI, K.G., BALCI, M.M., SEN, F., CANPOLAT, U., AKBOGA, M.K., UNAL, S., et al. The role of baseline indirect inflammatory markers in prediction of response to cardiac resynchronisation therapy. Kardiol. Pol. 2016;74(2):119–126.
- BAZOUKIS, G., SAPLAOURAS, A., LETSAS, K.P., YEUNG, C., XYDONAS, S., KARAMICHALAKIS, N., et al. The association of hematological indices with the response to cardiac resynchronization therapy: A single-center study. Hippokratia 2019;23(3):118–125.
- BALCI, K.G., BALCI, M.M., ARSLAN, U., AÇAR, B., MADEN, O., SELCUK, H., et al. Increased platelet-to-lymphocyte ratios and low relative lymphocyte counts predict appropriate shocks in heart failure patients with ICDs. Acta Cardiol. Sin. 2016;32(5):542–549.
- SEROPIAN, I.M., ROMEO, F.J., PIZARRO, R., VULCANO, N.O., POSATINI, R.A., MARENCHINO, R.G., et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation. ESC Hear. Fail. 2018;5(1):149–156.